New Delhi: The US Centers for Disease Control and Prevention had warned that many people who used Chennai-based Global Pharma Healthcare’s eye drops suffered adverse effects. Following this, Global Pharma Healthcare has withdrawn its drugs from the US market.
The U.S. Centers for Disease Control and Prevention was investigating side effects from artificial tear lubricant drops distributed by companies such as EzriCare, LLC, Telsam Pharma. In this regard, it recently sent a warning to the US Food and Drug Administration. It warned that many people have suffered from 55 adverse effects such as eye damage, permanent vision loss, and death due to blood infection.
Following this, in a warning issued by the Food and Drug Administration on Friday, the public and doctors should stop using and buying drugs from those companies. Using contaminated artificial tear drops can cause eye damage and lead to blindness and death. had informed that.
It has also recommended withdrawing the drugs from the market for allegations of inadequate microbiological testing and carelessness in packaging. The company is on the US Food and Drug Administration’s import ban list. This would prevent the company’s products from entering the US market.
Murali Neelakandan, former international consultant, Cipla, said, “The challenge with ophthalmic drugs or IV drops is that they work inside the body. And they have to be manufactured, packed and shipped in a very safe environment. In such a case, a company’s ophthalmic drugs shipped to the UK were contaminated.” It was found that the containers were not sent into the UK and that the eye drops were properly packed and were destroyed on the grounds that they might have been contaminated.
Caution should be exercised at every stage in the preparation of eye drops. A lot of care needs to be taken up to the drug manufacturing and distribution chain,” he said.
